目的 为临床药师参与动脉支架植入术后支架内血栓形成患者的治疗及药学监护提供参考。方法 临床药师通过参与动脉支架植入术后支架内血栓形成患者的治疗过程,结合患者疾病特点、用药史、药品不良反应等情况,建议医师选择合适的药物,提供个体化的药学服务。结果 临床药师利用药学专业知识配合基因检测等手段,协助临床医师为患者制定了个体化的给药方案,保障患者的用药安全。结论 临床药师在为患者提供个体化药学服务方面具有自身的优势,在合理用药中发挥了重要作用。
Abstract
OBJECTIVE To provide reference for the clinical pharmacists participating in the treatment of artery stent implantation in patients with stent thrombosis. METHODS Through participating in the course of treatment for an artery stent implantation in patients with stent thrombosis,combining with the disease characteristics of the patient,medication history and adverse drug reactions,clinical pharmacist suggested that doctors should select appropriate drugs for the patient,and the patient should be provided with individualized pharmaceutical care. RESULTS Clinical pharmacists use pharmacy expertise, with genetic testing and other means to assist clinicians for patients to develop individualized dosing regimen to protect the patient's medication safety. CONCLUSION Clinical pharmacists have their own advantages in providing individualized pharmaceutical care for patients. They play an important role in the rational use of drugs.
关键词
动脉支架植入术 /
支架内血栓形成 /
药学监护 /
个体化给药
{{custom_keyword}} /
Key words
left subclavian artery stent implantation /
stent thrombosis /
pharmaceutical care /
individual administration
{{custom_keyword}} /
中图分类号：
R969.3
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] XU Y Y,SHEN X F. Observation on a case of patient complicated with renal artery bleeding after left subclavian artery and left artery stent implantation[J].Chin Nurs Res(护理研究),2014,28(1):4096-4097.
[2] ARMSTRONG E J, FELDMAN D N,WANG T Y,et al. Clinical presentation,management,and outcomes of angiographically documented early,late,and very late stent thrombosis[J].JACC Cardiovasc Interv,2012,5(2):131-140.
[3] XU F X, GU M, ZHAO J D, et al. Review of the published articles on ADRs of aspirin[J].Journal of Military Surgeon in South west China(西南军医),2009,9(11):944-946.
[4] GUAN S Y, HAN Y L, LI Y,et al. Effect of different doses of cilostazol intensive antiplatelet therapy on the patients with high on-treatment platelet reactivity after coronary stent implantation[J].Pro Mod Biomed (现代生物医学进展),2013,10(29):5685-5688.
[5] THE CHINESE MEDICAL ASSOCIATION OF NEUROLOGY BRA- NCH OF ISCHEMIC CEREBROVASCULAR DISEASE GROUP OF NEUROLOGY BRANCH OF CHINESE MEDICAL CEREBROVASCULAR DISEASE GROUP ISCHEMIC STROKE SECONDARY PREVENTION GUIDELINES FOR WRITING. Guidelines of China for the prevention of stroke in patients with stroke and transient ischemic attack 2010[J].Chin J Neural(中华神经科杂志),2010,43(2):154-160.
[6] MEHTA S R, TANGUAY J F, EIKELBOOM J W, et al. Double-dose versusstandard-dose clopidogrel and high-dose versus low-dose aspirin inindividuals undergoing percutaneous coronary intervention for acutecoronary syndromes ( CURR ENT-OASIS 7): a randomised factorialtrial[J].Lancet,2010,376(9748):1233-1243.
[7] PATTI G, BRCZI G, ORLIC D, et al. Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: resultsfrom the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study[J].J Am Coll Cardiol,2011,58(15):1592-1599.
[8] SOLMAZ H, AKBULUT M, KORKMAZ H, et al. Effects of high loading dose of clopidogrel in ST elevated myocardial infarction treated with fibrinolytic agent[J].Clin Invest Med,2013,36(1):18-23.
[9] PRICE M J, BERGER P B, TEIRSTEIN P S, et al. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial[J].JAMA,2011,305(11):1097-1105.
[10] ZHANG L, CHEN Y, JIN Y, et al. Genetic determinants of high ontreatment platelet reactivity in clopidogrel treated Chinese patients[J].Thromb Res,2013,132(1):81-87.
[11] SHI Y J,CHEN F,JIN J J. CYP2C19 Polymorphism and clopidigrel resistance: research progres[J].Chin Heart J(心脏杂志),2014,26(5):603-606.
[12] DANG L L, YAO Y L, LIN R J. Efficacy and safety of triple antiplatelet therapy for patients with coronary heart diseases after percutaneous coronary intervention: a Meta-analysis[J]. Chin J Evid Based Med(中国循证医学杂志),2014,14(11):1351-1360.
[13] CHEN L. Analysis, assessment of adverse drug reaction of antithrombotics and procoagulant drugs,2005-2011[D]. Changsha:Central South University,2012.
[14] WANG S K. Comparative study of bisoprolol and metoprolol in treating dilated cardiomyopathy curative effect[J].Pract J Cardiac Cereb Pneum Vasc Dis(实用心脑肺血管病杂志),2014,5(22):18-19.
[15] CAI J Y. Clinical evaluation of trazodone in the teeatment of insomnia[J].Chin J Clin Pharm (中国临床药理学杂志), 2013,12(29):914-916.
[16] LI P. Clinical analysis of 68 cases of gastrointestinal bleeding caused by small dose aspirin[J]. Shangdong Med J(山东医药),2014,54(35):72-73.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
PDF(600 KB)
